Xenon and/or argon treatment as an adjunct to psychotherapy for psychiatric disorders
AssigneeThe McLean Hospital Corporation
InventorsEdward G. MELONI, Marc J. KAUFMAN
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to the fields of treating psychiatric disorders, in particular, anxiety disorders including post-traumatic stress disorder (PTSD) in subjects, e.g., human subjects, by administering a xenon and/or argon containing composition. Treatments can also employ psychotherapy in combination with administration of xenon and/or argon, alone or in combination with additional psychotherapeutic medications to treat the anxiety disorder and reduce a symptom of the anxiety disorder in the subject.
Claims2
A method for treating a subject with a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a xenon composition in combination with a session of psychotherapy, wherein during the session of psychotherapy the subject is exposed to a stimulus and trained to develop an altered response to said stimulus.
2-42. (canceled)
Dependencies are inferred from the claim text.